19 - Walgreens Boots Alliance

Courtesy of Walgreens

In December Walgreen’s announced a 40% stake in Sinopharm Holding Guoda Drugstores in China, expanding the company’s global reach. And the pharma retailer is getting into the data game, having spent over $500 million to-date on updating pharmacy management and data collection system and turning its 88.6 million user “Balance Rewards” program into a customer insight tool. Despite these expansion efforts and stronger than expected Q2 earnings, shareholders have watched the pharma retailer’s share price drop 22% since January, largely due to Amazon’s plan to sell prescription drugs to doctors and hospitals.

Key Metrics & Financials (Last Fiscal Year)

Previous Rank17
Revenues ($M)$118214
Revenue Percent Change0.7%
Profits ($M)$4078.0
Profits Percent Change-2.3%
Assets ($M)$66009
Market Value — as of March 29, 2018 ($M)$64924

More from FORTUNE

Company Facts

SectorFood & Drug Stores
IndustryFood and Drug Stores
HQ LocationDeerfield, Ill.
CEOStefano Pessina
CEO Title-
Years on Fortune 500 List24

See Full List


More from FORTUNE